Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence
A Randomized Clinical Trial
Bibliographic Data
clinicaltrials.gov Identifier: NCT01447212.
Anesthesia · Drug · Heroin · Hydromorphone · Opioid · Opioid use disorder · Randomized controlled trial · Cannabis and Cannabinoid Research · Forensic Toxicology and Drug Analysis · Internal Medicine · Medicine · Opioid Use Disorder Treatment · Pharmacology
An ethical defense of safer supply
La pratique émergente de la pharmacothérapie de remplacement
Le parcours québécois vers un traitement injectable pour le trouble d’usage d’opioïdes
Perspectives of people with opioid use disorder on improving addiction treatments and services
Implementing injectable opioid agonist treatment
Hydromorphone Hopes
‘I don't chase drugs as much anymore, and I'm not dead’
Community Pharmacy‐Based Injectable Opioid Agonist Treatment
Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder
Self‐managing illicit stimulant use
Prescribing safe supply
Solving the Opioid Crisis Isn't Just a Public Health Challenge—It's a Bioethics Challenge
Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder
It’s Helped Me a Lot, Just Like to Stay Alive”
Heroin and the illegal drug overdose death epidemic
Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder
How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose
Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis
It's too much, I'm getting really tired of it’
Employment and paid work among participants in a randomized controlled trial comparing diacetylmorphine and hydromorphone
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the Covid-19 global pandemic
Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing
Tackling the overdose crisis
Tracing a path for opium gum from Mexico as a safe supply harm reduction measure for Canada
A highly charged field
Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada
Principles, practice, and policy vacuums
Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia’s responses to opioid misuse
Repurposing prescribed hydromorphone
Mapping a moral panic
A concept mapping study of service user design of safer supply as an alternative to the illicit drug market
Investigating opioid preference to inform safe supply services
Safer opioid distribution in response to the Covid-19 pandemic
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during Covid-19 and the ongoing overdose emergency
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the Covid-19 pandemic
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada
Perspectives on prescribed safer supply programs among people who inject drugs in Baltimore, Maryland
The effect of Housing First on adherence to methadone maintenance treatment
Motivations to initiate injectable hydromorphone and diacetylmorphine treatment
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses
Trends in accidental drug overdose mortality in Canada
Addressing co-occurring public health emergencies
Consumer protection in drug policy
Addiction and Heroin-Assisted Treatment
Public support for safer supply programs
Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada
The machine doesn't judge
I'm just searching to get better
| Unique citing works | 50 |
|---|---|
| Citations per year | 5 |
| Citation span | 2016 - 2026 (11) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 50 |